Mll1 is essential for the senescenceassociated secretory phenotype

Brian C. Capell, Adam M. Drake, Jiajun Zhu, Parisha P. Shah, Zhixun Dou, Jean Dorsey, Daniel F. Simola, Greg Donahue, Morgan Sammons, Taranjit Singh Rai, Christopher Natale, Todd W. Ridky, Peter D. Adams, Shelley L. Berger

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Oncogene-induced senescence (OIS) and therapy-induced senescence (TIS), while tumor-suppressive, also promote procarcinogenic effects by activating the DNA damage response (DDR), which in turn induces inflammation. This inflammatory response prominently includes an array of cytokines known as the senescence-associated secretory phenotype (SASP). Previous observations link the transcription-associated methyltransferase and oncoprotein MLL1 to the DDR, leading us to investigate the role of MLL1 in SASP expression. Our findings reveal direct MLL1 epigenetic control over proproliferative cell cycle genes: MLL1 inhibition represses expression of proproliferative cell cycle regulators required for DNA replication and DDR activation, thus disabling SASP expression. Strikingly, however, these effects of MLL1 inhibition on SASP gene expression do not impair OIS and, furthermore, abolish the ability of the SASP to enhance cancer cell proliferation. More broadly, MLL1 inhibition also reduces “SASP-like” inflammatory gene expression from cancer cells in vitro and in vivo independently of senescence. Taken together, these data demonstrate that MLL1 inhibition may be a powerful and effective strategy for inducing cancerous growth arrest through the direct epigenetic regulation of proliferation-promoting genes and the avoidance of deleterious OIS- or TIS-related tumor secretomes, which can promote both drug resistance and tumor progression.

LanguageEnglish
Pages321-336
Number of pages16
JournalGenes and Development
Volume30
Issue number3
DOIs
Publication statusPublished - 1 Feb 2016

Fingerprint

Phenotype
Oncogenes
DNA Damage
Neoplasms
Epigenomics
Gene Expression
cdc Genes
Oncogene Proteins
Methyltransferases
DNA Replication
Drug Resistance
Cell Cycle
Cell Proliferation
Cytokines
Inflammation
Therapeutics
Growth
Genes

Keywords

  • DNA damage response
  • Epigenetic
  • Inflammation
  • MLL1
  • Oncogene-induced senescence
  • Senescence-associated secretory phenotype

Cite this

Capell, B. C., Drake, A. M., Zhu, J., Shah, P. P., Dou, Z., Dorsey, J., ... Berger, S. L. (2016). Mll1 is essential for the senescenceassociated secretory phenotype. Genes and Development, 30(3), 321-336. https://doi.org/10.1101/gad.271882.115
Capell, Brian C. ; Drake, Adam M. ; Zhu, Jiajun ; Shah, Parisha P. ; Dou, Zhixun ; Dorsey, Jean ; Simola, Daniel F. ; Donahue, Greg ; Sammons, Morgan ; Rai, Taranjit Singh ; Natale, Christopher ; Ridky, Todd W. ; Adams, Peter D. ; Berger, Shelley L. / Mll1 is essential for the senescenceassociated secretory phenotype. In: Genes and Development. 2016 ; Vol. 30, No. 3. pp. 321-336.
@article{95b1aee826744e888bc0999ca78b68dc,
title = "Mll1 is essential for the senescenceassociated secretory phenotype",
abstract = "Oncogene-induced senescence (OIS) and therapy-induced senescence (TIS), while tumor-suppressive, also promote procarcinogenic effects by activating the DNA damage response (DDR), which in turn induces inflammation. This inflammatory response prominently includes an array of cytokines known as the senescence-associated secretory phenotype (SASP). Previous observations link the transcription-associated methyltransferase and oncoprotein MLL1 to the DDR, leading us to investigate the role of MLL1 in SASP expression. Our findings reveal direct MLL1 epigenetic control over proproliferative cell cycle genes: MLL1 inhibition represses expression of proproliferative cell cycle regulators required for DNA replication and DDR activation, thus disabling SASP expression. Strikingly, however, these effects of MLL1 inhibition on SASP gene expression do not impair OIS and, furthermore, abolish the ability of the SASP to enhance cancer cell proliferation. More broadly, MLL1 inhibition also reduces “SASP-like” inflammatory gene expression from cancer cells in vitro and in vivo independently of senescence. Taken together, these data demonstrate that MLL1 inhibition may be a powerful and effective strategy for inducing cancerous growth arrest through the direct epigenetic regulation of proliferation-promoting genes and the avoidance of deleterious OIS- or TIS-related tumor secretomes, which can promote both drug resistance and tumor progression.",
keywords = "DNA damage response, Epigenetic, Inflammation, MLL1, Oncogene-induced senescence, Senescence-associated secretory phenotype",
author = "Capell, {Brian C.} and Drake, {Adam M.} and Jiajun Zhu and Shah, {Parisha P.} and Zhixun Dou and Jean Dorsey and Simola, {Daniel F.} and Greg Donahue and Morgan Sammons and Rai, {Taranjit Singh} and Christopher Natale and Ridky, {Todd W.} and Adams, {Peter D.} and Berger, {Shelley L.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1101/gad.271882.115",
language = "English",
volume = "30",
pages = "321--336",
journal = "Genes and Development",
issn = "0890-9369",
number = "3",

}

Capell, BC, Drake, AM, Zhu, J, Shah, PP, Dou, Z, Dorsey, J, Simola, DF, Donahue, G, Sammons, M, Rai, TS, Natale, C, Ridky, TW, Adams, PD & Berger, SL 2016, 'Mll1 is essential for the senescenceassociated secretory phenotype', Genes and Development, vol. 30, no. 3, pp. 321-336. https://doi.org/10.1101/gad.271882.115

Mll1 is essential for the senescenceassociated secretory phenotype. / Capell, Brian C.; Drake, Adam M.; Zhu, Jiajun; Shah, Parisha P.; Dou, Zhixun; Dorsey, Jean; Simola, Daniel F.; Donahue, Greg; Sammons, Morgan; Rai, Taranjit Singh; Natale, Christopher; Ridky, Todd W.; Adams, Peter D.; Berger, Shelley L.

In: Genes and Development, Vol. 30, No. 3, 01.02.2016, p. 321-336.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mll1 is essential for the senescenceassociated secretory phenotype

AU - Capell, Brian C.

AU - Drake, Adam M.

AU - Zhu, Jiajun

AU - Shah, Parisha P.

AU - Dou, Zhixun

AU - Dorsey, Jean

AU - Simola, Daniel F.

AU - Donahue, Greg

AU - Sammons, Morgan

AU - Rai, Taranjit Singh

AU - Natale, Christopher

AU - Ridky, Todd W.

AU - Adams, Peter D.

AU - Berger, Shelley L.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Oncogene-induced senescence (OIS) and therapy-induced senescence (TIS), while tumor-suppressive, also promote procarcinogenic effects by activating the DNA damage response (DDR), which in turn induces inflammation. This inflammatory response prominently includes an array of cytokines known as the senescence-associated secretory phenotype (SASP). Previous observations link the transcription-associated methyltransferase and oncoprotein MLL1 to the DDR, leading us to investigate the role of MLL1 in SASP expression. Our findings reveal direct MLL1 epigenetic control over proproliferative cell cycle genes: MLL1 inhibition represses expression of proproliferative cell cycle regulators required for DNA replication and DDR activation, thus disabling SASP expression. Strikingly, however, these effects of MLL1 inhibition on SASP gene expression do not impair OIS and, furthermore, abolish the ability of the SASP to enhance cancer cell proliferation. More broadly, MLL1 inhibition also reduces “SASP-like” inflammatory gene expression from cancer cells in vitro and in vivo independently of senescence. Taken together, these data demonstrate that MLL1 inhibition may be a powerful and effective strategy for inducing cancerous growth arrest through the direct epigenetic regulation of proliferation-promoting genes and the avoidance of deleterious OIS- or TIS-related tumor secretomes, which can promote both drug resistance and tumor progression.

AB - Oncogene-induced senescence (OIS) and therapy-induced senescence (TIS), while tumor-suppressive, also promote procarcinogenic effects by activating the DNA damage response (DDR), which in turn induces inflammation. This inflammatory response prominently includes an array of cytokines known as the senescence-associated secretory phenotype (SASP). Previous observations link the transcription-associated methyltransferase and oncoprotein MLL1 to the DDR, leading us to investigate the role of MLL1 in SASP expression. Our findings reveal direct MLL1 epigenetic control over proproliferative cell cycle genes: MLL1 inhibition represses expression of proproliferative cell cycle regulators required for DNA replication and DDR activation, thus disabling SASP expression. Strikingly, however, these effects of MLL1 inhibition on SASP gene expression do not impair OIS and, furthermore, abolish the ability of the SASP to enhance cancer cell proliferation. More broadly, MLL1 inhibition also reduces “SASP-like” inflammatory gene expression from cancer cells in vitro and in vivo independently of senescence. Taken together, these data demonstrate that MLL1 inhibition may be a powerful and effective strategy for inducing cancerous growth arrest through the direct epigenetic regulation of proliferation-promoting genes and the avoidance of deleterious OIS- or TIS-related tumor secretomes, which can promote both drug resistance and tumor progression.

KW - DNA damage response

KW - Epigenetic

KW - Inflammation

KW - MLL1

KW - Oncogene-induced senescence

KW - Senescence-associated secretory phenotype

UR - http://www.scopus.com/inward/record.url?scp=84957805975&partnerID=8YFLogxK

U2 - 10.1101/gad.271882.115

DO - 10.1101/gad.271882.115

M3 - Article

VL - 30

SP - 321

EP - 336

JO - Genes and Development

T2 - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 3

ER -

Capell BC, Drake AM, Zhu J, Shah PP, Dou Z, Dorsey J et al. Mll1 is essential for the senescenceassociated secretory phenotype. Genes and Development. 2016 Feb 1;30(3):321-336. https://doi.org/10.1101/gad.271882.115